ICL Stock Overview
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide.
ICL Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₪32.85|
|52 Week High||₪41.58|
|52 Week Low||₪21.51|
|1 Month Change||-10.76%|
|3 Month Change||-14.07%|
|1 Year Change||48.58%|
|3 Year Change||76.33%|
|5 Year Change||104.29%|
|Change since IPO||1,183.20%|
Recent News & Updates
ICL Group Ltd (TLV:ICL) Shares Could Be 25% Above Their Intrinsic Value Estimate
Does the June share price for ICL Group Ltd ( TLV:ICL ) reflect what it's really worth? Today, we will estimate the...
Analysts Just Made A Captivating Upgrade To Their ICL Group Ltd (TLV:ICL) Forecasts
Celebrations may be in order for ICL Group Ltd ( TLV:ICL ) shareholders, with the analysts delivering a significant...
|ICL||IL Chemicals||IL Market|
Return vs Industry: ICL matched the IL Chemicals industry which returned 47.7% over the past year.
Return vs Market: ICL exceeded the IL Market which returned 9.5% over the past year.
|ICL Average Weekly Movement||5.7%|
|Chemicals Industry Average Movement||5.2%|
|Market Average Movement||5.6%|
|10% most volatile stocks in IL Market||9.0%|
|10% least volatile stocks in IL Market||3.6%|
Stable Share Price: ICL is not significantly more volatile than the rest of IL stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ICL's weekly volatility (6%) has been stable over the past year.
About the Company
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
ICL Group Fundamentals Summary
|ICL fundamental statistics|
Is ICL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ICL income statement (TTM)|
|Cost of Revenue||US$4.61b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Jul 27, 2022
|Earnings per share (EPS)||0.99|
|Net Profit Margin||16.06%|
How did ICL perform over the long term?See historical performance and comparison
3.3%Current Dividend Yield
Is ICL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ICL?
Other financial metrics that can be useful for relative valuation.
|What is ICL's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ICL's PE Ratio compare to its peers?
|ICL PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
YAR Yara International
ICL ICL Group
Price-To-Earnings vs Peers: ICL is good value based on its Price-To-Earnings Ratio (9.5x) compared to the peer average (11.6x).
Price to Earnings Ratio vs Industry
How does ICL's PE Ratio compare vs other companies in the Asian Chemicals Industry?
Price-To-Earnings vs Industry: ICL is good value based on its Price-To-Earnings Ratio (9.5x) compared to the IL Chemicals industry average (10.2x)
Price to Earnings Ratio vs Fair Ratio
What is ICL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||9.5x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ICL's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of ICL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ICL (₪32.85) is trading above our estimate of fair value (₪28.31)
Significantly Below Fair Value: ICL is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: ICL's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Discover undervalued companies
How is ICL Group forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ICL's earnings are forecast to decline over the next 3 years (-33% per year).
Earnings vs Market: ICL's earnings are forecast to decline over the next 3 years (-33% per year).
High Growth Earnings: ICL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ICL's revenue is expected to decline over the next 3 years (-8.9% per year).
High Growth Revenue: ICL's revenue is forecast to decline over the next 3 years (-8.9% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ICL's Return on Equity is forecast to be low in 3 years time (12.1%).
Discover growth companies
How has ICL Group performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ICL has high quality earnings.
Growing Profit Margin: ICL's current net profit margins (16.1%) are higher than last year (1.6%).
Past Earnings Growth Analysis
Earnings Trend: ICL has become profitable over the past 5 years, growing earnings by 3.3% per year.
Accelerating Growth: ICL's earnings growth over the past year (1388.4%) exceeds its 5-year average (3.3% per year).
Earnings vs Industry: ICL earnings growth over the past year (1388.4%) exceeded the Chemicals industry 23.8%.
Return on Equity
High ROE: ICL's Return on Equity (25.3%) is considered high.
Discover strong past performing companies
How is ICL Group's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ICL's short term assets ($4.5B) exceed its short term liabilities ($2.7B).
Long Term Liabilities: ICL's short term assets ($4.5B) exceed its long term liabilities ($3.7B).
Debt to Equity History and Analysis
Debt Level: ICL's net debt to equity ratio (44.7%) is considered high.
Reducing Debt: ICL's debt to equity ratio has reduced from 126.1% to 54.7% over the past 5 years.
Debt Coverage: ICL's debt is well covered by operating cash flow (40.7%).
Interest Coverage: ICL's interest payments on its debt are well covered by EBIT (18x coverage).
Discover healthy companies
What is ICL Group current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ICL's dividend (3.27%) is higher than the bottom 25% of dividend payers in the IL market (2.03%).
High Dividend: ICL's dividend (3.27%) is low compared to the top 25% of dividend payers in the IL market (6.18%).
Stability and Growth of Payments
Stable Dividend: ICL's dividend payments have been volatile in the past 10 years.
Growing Dividend: ICL's dividend payments have fallen over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (49.7%), ICL's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (67.7%), ICL's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Raviv Zoller (57 yo)
Mr. Raviv Zoller serves as the President of ICL Group Ltd. (formerly known as Israel Chemicals Limited) since 2018 and Chief Executive Officer since May 14, 2018. Mr. Zoller served as the Chief Executive O...
CEO Compensation Analysis
Compensation vs Market: Raviv's total compensation ($USD3.27M) is above average for companies of similar size in the IL market ($USD2.02M).
Compensation vs Earnings: Raviv's compensation has been consistent with company performance over the past year.
Experienced Management: ICL's management team is considered experienced (3 years average tenure).
Experienced Board: ICL's board of directors are considered experienced (4.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
ICL Group Ltd's employee growth, exchange listings and data sources
- Name: ICL Group Ltd
- Ticker: ICL
- Exchange: TASE
- Founded: 1968
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Implied Market Cap: ₪42.283b
- Shares outstanding: 1.29b
- Website: https://www.icl-group.com
Number of Employees
- ICL Group Ltd
- Millenium Tower
- 23 Aranha Street
- Tel Aviv
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/29 00:00|
|End of Day Share Price||2022/06/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.